The Promising Pathway Act reintroduced in the Senate on May 13, 2021 will expedite beneficial outcomes for patients by requiring the Food and Drug Administration (FDA) to establish a rolling, real-time, priority review pathway for drugs intended to treat, prevent, or diagnose serious or life-threatening diseases or conditions.
Media Contact: Theresa Garner, theresa@iamals.org
Promising Pathway Act 2021 Updates
- Read Senator Braun’s press release announcing the reintroduction of the Promising Pathway Act in the 117th Congress
- Read Representative Westerman’s press release announcing the reintroduction of the Promising Pathway Act in the 117th House of Representatives
Promising Pathway Act 2020 Updates
- Read our press release
- Read the press release published by Senator Braun and colleagues
- Read the press release published by Representative Gallagher and colleagues
- Review the Senate bill and its co-sponsors on Congress.gov
- Review the House bill and its co-sponsors on Congress.gov